PEAK PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - August 13, 2018

Attached files

file	filename
EX-32.2 - SECTION 906 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.	ex32-2.htm
EX-31.2 - SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.	ex31-2.htm
EX-31.1 - SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL - PEAK PHARMACEUTICALS, INC.	ex31-1.htm
EX-10.2 - CONVERTIBLE PROMISSORY NOTE DATED MARCH 30, 2017 WITH SUKH ATHWAL - PEAK PHARMACEUTICALS, INC.	ex10-2.htm
EX-10.1 - CONVERTIBLE PROMISSORY NOTE DATED MARCH 21, 2017 WITH TRIUS HOLDINGS LIMITED - PEAK PHARMACEUTICALS, INC.	ex10-1.htm
10-Q - PEAK PHARMACEUTICALS, INC. 10-Q - PEAK PHARMACEUTICALS, INC.	peak_10q-17437.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Neil Reithinger, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a)	The quarterly report on Form 10-Q of Peak Pharmaceuticals, Inc. for the quarter ended June 30, 2018 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)	Information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	August 13, 2018

By:	/s/ Neil Reithinger
Name:	Neil Reithinger
Title:	Chief Executive Officer (Principal Executive Officer)